Evaluation of stigmatization and quality of life before and after botulinum toxin treatment in hemifacial spasm
Objective: Hemifacial spasm (HFS) is a chronic disease that is characterized by involuntary tonic and clonic contractions of the muscles innervated by the ipsilateral facial…Botulinum neurotoxin type A versus anticholinergics for cervical dystonia in adults – 2016 Cochrane movement disorders group systematic review update
Objective: To compare the effects of botulinum toxin A (BtA) versus anticholinergics in adults with cervical dystonia (CD). Background: This is an update of a…Highlighting the spectrum of practice in the routine management of cervical dystonia with botulinum neurotoxin-A: Baseline injection practice data from MetaCD
Objective: To describe the spectrum of routine injection practice for botulinum neurotoxin-A (BoNT-A) in the management of cervical dystonia (CD). Background: The success of each…Botulinum neurotoxin type A versus placebo for hemifacial spasm in adults – 2016 Cochrane movement disorders group systematic review update
Objective: To update a Cochrane review comparing botulinum neurotoxin type A (BtA) to placebo in adults with hemifacial spasm (HFS). Background: This is an update…How satisfied are cervical dystonia patients with their botulinum toxin treatment? Findings from an international observational study
Objective: Evaluate patient satisfaction with botulinum neurotoxin-A (BoNT-A) treatment over an injection cycle in routine practice. Background: Benefits of BoNT-A injection in cervical dystonia (CD)…Botulinum neurotoxins type A versus B for cervical dystonia in adults – 2016 Cochrane movement disorders group systematic review update
Objective: To update a Cochrane review comparing botulinum neurotoxin type A (BtA) to type B (BtB) in adults with cervical dystonia (CD). Background: This is…AbobotulinumtoxinA for cervical dystonia: International treatment patterns
Objective: To characterise international dosing practice for abobotulinumtoxinA (Dysport®, ABO) for cervical dystonia (CD) in a large observational study. Background: The safety and efficacy of…Botulinum toxin type A therapy for blepharospasm – Update of a Cochrane systematic review and meta-analysis
Objective: To compare the effects of botulinum toxin type A (BtA) versus placebo in blepharospasm. Background: This is an update of a Cochrane systematic review.…Multicentre retrospective chart review of patients treated with incobotulinumtoxinA to evaluate sustained efficacy and tolerability in converted and de-novo conditions
Objective: This study aimed to determine whether IncobotulinumtoxinA (IBTX) provides sustained efficacy as a treatment modality patients in both de-novo patients and patients converted from…Botulinum toxin type B therapy for cervical dystonia – 2015 update of a Cochrane systematic review and meta-analysis
Objective: To compare the effects of botulinum toxin type B (BtB) versus placebo in cervical dystonia (CD). Background: This is an update of a Cochrane…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.